aTYR PHARMA INC (ATYR) stock
ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.08−0.91 (-18.24%)
Close on Nov 18, 2026Market cap $400.20MP/E –Yield –
aTYR PHARMA pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
No pe ratio figures for aTYR PHARMA
aTYR PHARMA has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?